The product is disappearing into reorder rhythm: revenue is shifting from won-each-time to arriving-on-its-own, and the
The model's full reasoning — Q4 2021 call → NOWe need answer only YES or NO. Need analyze transcript. Question asks: Does management describe that a growing share of company's revenue now arrives without a new selling event — through reorders, refills, renewals, repeat purchases, usage-driven billing, aftermarket or consumable pull-through, or customers' own standing routines — AND that this self-arriving share has recently and visibly grown as a proportion of the business, with management grounding the shift in observed current behavior and treating it as changing company's quality of revenue? Need use only transcript. Need determine if management describes such. Company Vanda Pharmaceuticals, products HETLIOZ and Fanapt. Revenue from prescriptions. They discuss HETLIOZ prescriptions, payer denials, patients on treatment. But do they describe self-arriving revenue? They talk about "new patient prescriptions" and "net decline of Non-24 patients in treatment." They mention "HETLIOZ demand continues to far exceed prescriptions filled" and "patients on therapy." But no explicit discussion of recurring revenue as growing share. They discuss SMS launch, more than 50 patients on treatment. But no mention of reorders/refills/renewals as revenue mechanism. They discuss payer challenges, access. No mention of installed base generating recurring revenue. The question is about "self-arriving revenue" without new selling event. In pharma, prescriptions are refilled, but management doesn't describe that as a growing share. They talk about net patient counts, payer denials. No mention of "recurring revenue" or "repeat purchases" as a shift. They do mention "HETLIOZ demand continues to far exceed the prescriptions filled" but that's about demand vs access. No. Need answer NO.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| DUOT | Duos Technologies Group, Inc. | Q4 2023 | 2024-04-01 | F |
| QTRX | Quanterix Corporation | Q3 2023 | 2023-11-07 | B |
| CYBR | CyberArk Software Ltd. | Q3 2021 | 2021-11-04 | B+ |
| IRBT | iRobot Corporation | Q3 2021 | 2021-10-28 | D |
| TOUR | Tuniu Corporation | Q4 2017 | 2018-03-14 | D |
DUOT · Q4 2023 → YESThe question is about whether management describes a growing share of revenue arriving without a new selling event, through reorders, renewals, etc., and that this has recently and visibly grown as a ...
QTRX · Q3 2023 → YESThe question is about whether management describes a growing share of revenue arriving without a new selling event, like through reorders, consumables, etc., and that this share has recently grown.
CYBR · Q3 2021 → YESThe question is about whether management describes a growing share of revenue arriving without a new selling event, like through renewals, and that this has recently grown as a proportion.